|
2022-08-12 |
2022-08-11 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
1.678.954
+24.1%
10,07
16.907.067 USD
|
1.678.954
+24.1%
|
10,07
|
16.907.067 USD
|
|
|
2022-08-11 |
2022-08-10 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
4.012
+0.1%
10,07
40.401 USD
|
4.012
+0.1%
|
10,07
|
40.401 USD
|
|
|
2022-05-20 |
2022-05-18 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
477.824
+5.8%
5,57
2.661.002 USD
|
477.824
+5.8%
|
5,57
|
2.661.002 USD
|
|
|
2022-01-07 |
2022-01-06 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
300.000
+3.8%
6,31
1.894.410 USD
|
300.000
+3.8%
|
6,31
|
1.894.410 USD
|
|
|
2022-01-07 |
2022-01-05 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
250.000
+3.2%
6,30
1.574.650 USD
|
250.000
+3.2%
|
6,30
|
1.574.650 USD
|
|
|
2021-12-16 |
2021-12-16 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
146.685
+2.2%
7,07
1.037.752 USD
|
146.685
+2.2%
|
7,07
|
1.037.752 USD
|
|
|
2021-12-15 |
2021-12-15 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
180.744
+2.7%
6,77
1.223.637 USD
|
180.744
+2.7%
|
6,77
|
1.223.637 USD
|
|
|
2021-12-15 |
2021-12-14 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
94.103
+1.4%
6,81
640.936 USD
|
94.103
+1.4%
|
6,81
|
640.936 USD
|
|
|
2021-12-15 |
2021-12-13 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
187.391
+3.0%
7,08
1.326.803 USD
|
187.391
+3.0%
|
7,08
|
1.326.803 USD
|
|
|
2021-12-10 |
2021-12-10 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
768.171
+13.8%
7,18
5.511.627 USD
|
768.171
+13.8%
|
7,18
|
5.511.627 USD
|
|
|
2021-12-10 |
2021-12-09 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
264.644
+5.0%
7,58
2.007.087 USD
|
264.644
+5.0%
|
7,58
|
2.007.087 USD
|
|
|
2021-12-10 |
2021-12-08 |
K
Kauf
|
Rubric Capital Management LP
Large shareholder
|
560.691
+11.8%
8,02
4.497.078 USD
|
560.691
+11.8%
|
8,02
|
4.497.078 USD
|
|
|
2021-10-01 |
2021-09-29 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
100.000
+1.3%
12,95
1.294.500 USD
|
100.000
+1.3%
|
12,95
|
1.294.500 USD
|
|
|
2021-03-09 |
2021-03-05 |
GV
Geplanter Verkauf
|
Chopas James George
Principal Finance Accounting
Führungsperson
|
370
-5.2%
20,88
7.726 USD
|
370
-5.2%
|
20,88
|
7.726 USD
|
|
|
2021-02-26 |
2021-02-25 |
V
Verkauf
|
Grausso Sal
Chief Commercial Officer
Führungsperson
|
1.322
-10.1%
18,93
25.025 USD
|
1.322
-10.1%
|
18,93
|
25.025 USD
|
|
|
2020-11-09 |
2020-11-05 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
100.000
+1.4%
14,26
1.426.230 USD
|
100.000
+1.4%
|
14,26
|
1.426.230 USD
|
|
|
2020-09-16 |
2020-09-14 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
200.000
+2.8%
11,69
2.338.680 USD
|
200.000
+2.8%
|
11,69
|
2.338.680 USD
|
|
|
2020-09-14 |
2020-09-11 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
199.029
+2.9%
11,33
2.255.118 USD
|
199.029
+2.9%
|
11,33
|
2.255.118 USD
|
|
|
2020-07-09 |
2020-07-08 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
25.000
+0.4%
13,21
330.178 USD
|
25.000
+0.4%
|
13,21
|
330.178 USD
|
|
|
2020-05-04 |
2020-04-30 |
K
Kauf
|
BIOTECH TARGET N V
Large shareholder
|
50.000
+0.7%
15,75
787.555 USD
|
50.000
+0.7%
|
15,75
|
787.555 USD
|
|
|
2020-02-28 |
2020-02-26 |
GV
Geplanter Verkauf
|
Hughes Owen
Nicht geschäftsführender Verwaltungsratsmitglied
|
2.750
-20.5%
17,95
49.363 USD
|
2.750
-20.5%
|
17,95
|
49.363 USD
|
|
|
2020-02-28 |
2020-02-26 |
V
Verkauf
|
Carmona Jose
Chief Financial Officer
Führungsperson
|
1.292
-2.7%
17,93
23.169 USD
|
1.292
-2.7%
|
17,93
|
23.169 USD
|
|
|
2020-02-28 |
2020-02-26 |
GV
Geplanter Verkauf
|
Dere Willard H
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.925
-13.6%
17,95
34.554 USD
|
1.925
-13.6%
|
17,95
|
34.554 USD
|
|
|
2020-02-28 |
2020-02-26 |
V
Verkauf
|
Morris Charles Q
Chief Medical Officer
Führungsperson
|
1.256
-3.6%
17,93
22.524 USD
|
1.256
-3.6%
|
17,93
|
22.524 USD
|
|
|
2020-02-28 |
2020-02-26 |
GV
Geplanter Verkauf
|
Rosenberg Anthony
Nicht geschäftsführender Verwaltungsratsmitglied
|
1.815
-12.8%
17,95
32.579 USD
|
1.815
-12.8%
|
17,95
|
32.579 USD
|
|
|
2020-02-28 |
2020-02-26 |
V
Verkauf
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Führungsperson
|
889
-3.6%
17,93
15.942 USD
|
889
-3.6%
|
17,93
|
15.942 USD
|
|
|
2019-11-08 |
2019-11-06 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
100.000
+1.5%
23,00
2.300.300 USD
|
100.000
+1.5%
|
23,00
|
2.300.300 USD
|
|
|
2019-07-03 |
2019-07-01 |
GV
Geplanter Verkauf
|
Rosenberg Anthony
|
1.584
-15.4%
24,60
38.966 USD
|
1.584
-15.4%
|
24,60
|
38.966 USD
|
|
|
2019-06-11 |
2019-06-07 |
K
Kauf
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2.500
+50.0%
21,81
54.536 USD
|
2.500
+50.0%
|
21,81
|
54.536 USD
|
|
|
2019-05-13 |
2019-05-10 |
K
Kauf
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
|
2.000
+66.7%
21,43
42.860 USD
|
2.000
+66.7%
|
21,43
|
42.860 USD
|
|
|
2019-04-18 |
2019-04-16 |
GV
Geplanter Verkauf
|
Dere Willard H
|
1.680
-16.3%
22,22
37.330 USD
|
1.680
-16.3%
|
22,22
|
37.330 USD
|
|
|
2019-04-18 |
2019-04-16 |
GV
Geplanter Verkauf
|
Graves Kurt
|
4.800
-46.6%
22,32
107.136 USD
|
4.800
-46.6%
|
22,32
|
107.136 USD
|
|
|
2019-04-18 |
2019-04-16 |
GV
Geplanter Verkauf
|
Hughes Owen
|
2.400
-23.3%
22,22
53.328 USD
|
2.400
-23.3%
|
22,22
|
53.328 USD
|
|
|
2019-04-12 |
2019-04-11 |
GV
Geplanter Verkauf
|
Roychowdhury Debasish
|
4.800
-46.6%
22,15
106.320 USD
|
4.800
-46.6%
|
22,15
|
106.320 USD
|
|
|
2019-03-06 |
2019-03-05 |
K
Kauf
|
Hopfield Jessica
|
12.800
+inf%
19,23
246.190 USD
|
12.800
+inf%
|
19,23
|
246.190 USD
|
|
|
2018-12-21 |
2018-12-20 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+0.9%
14,48
868.782 USD
|
60.000
+0.9%
|
14,48
|
868.782 USD
|
|
|
2018-12-18 |
2018-12-17 |
K
Kauf
|
Kelly Joseph Francis
Sr. VP of Sales and Marketing
Führungsperson
|
3.000
+inf%
15,71
47.130 USD
|
3.000
+inf%
|
15,71
|
47.130 USD
|
|
|
2018-12-17 |
2018-12-14 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+0.9%
15,64
938.256 USD
|
60.000
+0.9%
|
15,64
|
938.256 USD
|
|
|
2018-08-22 |
2018-08-20 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+0.9%
19,65
1.178.808 USD
|
60.000
+0.9%
|
19,65
|
1.178.808 USD
|
|
|
2018-08-16 |
2018-08-15 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
69.363
+1.1%
20,78
1.441.530 USD
|
69.363
+1.1%
|
20,78
|
1.441.530 USD
|
|
|
2018-08-16 |
2018-08-14 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
100.000
+1.6%
20,87
2.086.880 USD
|
100.000
+1.6%
|
20,87
|
2.086.880 USD
|
|
|
2018-08-10 |
2018-08-08 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+1.0%
22,73
1.363.884 USD
|
60.000
+1.0%
|
22,73
|
1.363.884 USD
|
|
|
2018-07-30 |
2018-07-27 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.8%
24,81
1.240.605 USD
|
50.000
+0.8%
|
24,81
|
1.240.605 USD
|
|
|
2018-07-26 |
2018-07-25 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.8%
27,28
1.363.805 USD
|
50.000
+0.8%
|
27,28
|
1.363.805 USD
|
|
|
2018-06-13 |
2018-06-11 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.8%
27,36
1.367.835 USD
|
50.000
+0.8%
|
27,36
|
1.367.835 USD
|
|
|
2018-05-24 |
2018-05-23 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
40.000
+0.7%
28,91
1.156.320 USD
|
40.000
+0.7%
|
28,91
|
1.156.320 USD
|
|
|
2018-05-23 |
2018-05-21 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+1.0%
29,27
1.756.380 USD
|
60.000
+1.0%
|
29,27
|
1.756.380 USD
|
|
|
2018-04-23 |
2018-04-19 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
40.000
+0.7%
33,80
1.351.936 USD
|
40.000
+0.7%
|
33,80
|
1.351.936 USD
|
|
|
2018-04-09 |
2018-04-05 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
36,58
1.828.845 USD
|
50.000
+0.9%
|
36,58
|
1.828.845 USD
|
|
|
2018-03-06 |
2018-03-02 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
80.000
+1.4%
32,52
2.601.448 USD
|
80.000
+1.4%
|
32,52
|
2.601.448 USD
|
|
|
2018-02-12 |
2018-02-09 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
75.000
+1.3%
34,38
2.578.763 USD
|
75.000
+1.3%
|
34,38
|
2.578.763 USD
|
|
|
2017-11-16 |
2017-11-14 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
26,25
1.312.390 USD
|
50.000
+0.9%
|
26,25
|
1.312.390 USD
|
|
|
2017-11-13 |
2017-11-10 |
K
Kauf
|
Hatzis-Schoch Brent
Sr. VP, General Counsel
|
1.778
+355.6%
28,09
49.943 USD
|
1.778
+355.6%
|
28,09
|
49.943 USD
|
|
|
2017-11-07 |
2017-11-07 |
K
Kauf
|
Hoiland Jesper
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
6.800
+111.5%
29,04
197.450 USD
|
6.800
+111.5%
|
29,04
|
197.450 USD
|
|
|
2017-11-07 |
2017-11-03 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
29,15
1.457.575 USD
|
50.000
+0.9%
|
29,15
|
1.457.575 USD
|
|
|
2017-10-27 |
2017-10-26 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
30,95
1.547.550 USD
|
50.000
+0.9%
|
30,95
|
1.547.550 USD
|
|
|
2017-10-26 |
2017-10-25 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
32,85
1.642.415 USD
|
50.000
+0.9%
|
32,85
|
1.642.415 USD
|
|
|
2017-09-15 |
2017-09-15 |
K
Kauf
|
Hoiland Jesper
President and CEO
Geschäftsführender Verwaltungsratsmitglied
|
6.100
+inf%
32,72
199.608 USD
|
6.100
+inf%
|
32,72
|
199.608 USD
|
|
|
2017-09-15 |
2017-09-14 |
K
Kauf
|
Carmona Jose
Chief Financial Officer
|
3.000
+inf%
32,83
98.503 USD
|
3.000
+inf%
|
32,83
|
98.503 USD
|
|
|
2017-09-15 |
2017-09-14 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
32,94
1.647.225 USD
|
50.000
+0.9%
|
32,94
|
1.647.225 USD
|
|
|
2017-09-15 |
2017-09-13 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
100.000
+1.9%
33,71
3.370.750 USD
|
100.000
+1.9%
|
33,71
|
3.370.750 USD
|
|
|
2017-09-13 |
2017-09-12 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+0.9%
35,42
1.770.820 USD
|
50.000
+0.9%
|
35,42
|
1.770.820 USD
|
|
|
2017-09-07 |
2017-09-05 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+1.0%
36,75
1.837.625 USD
|
50.000
+1.0%
|
36,75
|
1.837.625 USD
|
|
|
2017-08-18 |
2017-08-16 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
60.000
+1.2%
35,98
2.158.536 USD
|
60.000
+1.2%
|
35,98
|
2.158.536 USD
|
|
|
2017-08-11 |
2017-08-10 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
75.000
+1.5%
34,26
2.569.500 USD
|
75.000
+1.5%
|
34,26
|
2.569.500 USD
|
|
|
2017-08-11 |
2017-08-09 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
75.000
+1.5%
35,67
2.675.528 USD
|
75.000
+1.5%
|
35,67
|
2.675.528 USD
|
|
|
2017-05-31 |
2017-05-30 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
40.000
+0.8%
34,21
1.368.348 USD
|
40.000
+0.8%
|
34,21
|
1.368.348 USD
|
|
|
2017-05-30 |
2017-05-25 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
40.000
+0.8%
36,25
1.450.020 USD
|
40.000
+0.8%
|
36,25
|
1.450.020 USD
|
|
|
2017-05-22 |
2017-05-18 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+1.0%
34,41
1.720.345 USD
|
50.000
+1.0%
|
34,41
|
1.720.345 USD
|
|
|
2017-05-18 |
2017-05-17 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
18.000
+0.4%
32,98
593.662 USD
|
18.000
+0.4%
|
32,98
|
593.662 USD
|
|
|
2017-05-18 |
2017-05-16 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
17.000
+0.3%
33,93
576.725 USD
|
17.000
+0.3%
|
33,93
|
576.725 USD
|
|
|
2017-05-16 |
2017-05-12 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
15.000
+0.3%
34,00
509.996 USD
|
15.000
+0.3%
|
34,00
|
509.996 USD
|
|
|
2017-05-11 |
2017-05-09 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
50.000
+1.0%
35,93
1.796.480 USD
|
50.000
+1.0%
|
35,93
|
1.796.480 USD
|
|
|
2017-05-09 |
2017-05-08 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
22.800
+0.5%
35,60
811.630 USD
|
22.800
+0.5%
|
35,60
|
811.630 USD
|
|
|
2017-05-09 |
2017-05-05 |
K
Kauf
|
BIOTECH GROWTH N V
Large shareholder
|
20.600
+0.4%
35,55
732.283 USD
|
20.600
+0.4%
|
35,55
|
732.283 USD
|
|
